Novartis stock holds steady as market cap stays near $295 billion
Published on 08/28/2026 at 18:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novartis stock held near $154.54 on August 28, 2026, while its market cap stood at $294.88 billion and its 52-week range stretched from $121.57 to $170.46.
The latest market snapshot also showed a 50-day moving average of $154.94 and a 200-day moving average of $153.78, a narrow spread that leaves the shares close to their medium-term trend.
Valuation stays firm
Novartis AG has a price-to-earnings ratio of 23.31 and a beta of 0.45, which places the stock in a relatively low-volatility profile for a large-cap healthcare name.
The share count and valuation data point to a stock that is not trading at a deep discount to its own history, even after moving within a 52-week band of more than $48.
Consensus points lower
MarketBeat data cited in recent filings showed an average rating of Hold and an average target price of $141.20, which sits below the $154.54 opening price reported on August 28, 2026.
That gap of $13.34 is a concrete reminder that the consensus view remains more cautious than the current quote.
Novartis medicines
Novartis' portfolio spans oncology, immunology, neuroscience and cardiovascular medicines, with flagship products such as Entresto, Cosentyx and Kisqali still central to the company’s revenue mix.
Stock view
Novartis stock was priced at $154.54 on August 28, 2026, with a market cap of $294.88 billion and a 52-week high of $170.46.
Company
Company: Novartis AG
ISIN: CH0012005267
Ticker: NVS
Exchange: NYSE
Price (as of August 28, 2026): $154.54 USD
Market cap: $294.88 billion (as of August 28, 2026)
Sector / Industry: Health Care / Pharmaceuticals
Index membership: S&P 500
